Assessing Bayer (XTRA:BAYN) Valuation After Recent Share Price Rebound And Conflicting Fair Value Signals [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Event context and recent share performance Bayer (XTRA:BAYN) has been drawing attention after a period of mixed share performance, with the stock up about 5% over the past week while showing a small decline over the past month. See our latest analysis for Bayer. At a share price of €40.12, Bayer's recent 7 day share price return of 5.22% sits against a 1 year total shareholder return of 88.16%, while the 3 year total shareholder return remains negative at 29.15%. This suggests some momentum has returned after a weaker multi year period. If this kind of rebound has your attention, it could be a good moment to broaden your watchlist and check out 122 healthcare AI stocks With Bayer trading at €40.12 and sitting below some analyst price estimates, the key question for you is simple: is the current valuation overlooking future potential, or is the market already pricing in what comes next
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- What to know about the battle over lawsuits alleging that Roundup weedkiller can cause cancer 1 / 5 [Yahoo! Finance Canada]Yahoo! Finance Canada
- Federal health and environmental agencies to study microplastics and pharmaceuticals in drinking water [Los Angeles Times (CA)]Los Angeles Times
- Booker urges Supreme Court to allow Roundup cancer lawsuits to proceed [CBS News]CBS News
- AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure [Yahoo! Finance]Yahoo! Finance
- AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure [TheStreet.com]TheStreet.com